The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

HANNA Newnham developed a life-threatening allergy to the cold after catching Covid-19. Now, she can’t exercise outdoors in ...

Hanna Newnham, from Brighton, first noticed symptoms of cold urticaria – hives that appear after cold temperature exposure – after recovering from Covid-19 in 2020. The hives first appeared in ...

Pictures of hives, also known as urticaria, can help you to identify these raised ... and other allergens When your body comes into contact with an allergen it triggers an immune response in which an ...

TUESDAY, March 11, 2025 (HealthDay News) -- For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H 1-antihistamines, administration of the oral, highly ...

For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H 1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase ...

SAN DIEGO — Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch and urticaria activity with dupilumab, according to a ...

Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, reduced itch and hives in patients with chronic spontaneous urticaria and showed a favorable safety profile at week 12 in two trials.

Dr Ruchi Gupta attended the AAAAI/WAO conference in San Diego, where she explored key updates in anaphylaxis, angioedema, and chronic spontaneous urticaria (CSU). A major highlight was the ...